Man Group PLC Seres Therapeutics, Inc. Transaction History

Man Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$4.67 - $6.55 $61,555 - $86,335	13,181 New	13,181 $63,000
Q2 2021 Aug 16, 2021	SELL	$18.46 - $24.36 $371,747 - $490,561	-20,138 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$17.66 - $28.92 $195,072 - $319,450	11,046 Added 121.49%	20,138 $415,000
Q4 2020 Feb 16, 2021	BUY	$23.25 - $37.73 $211,389 - $343,041	9,092 New	9,092 $223,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.